éå»1ã¶æéã«Zenas Biopharma Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã8åã«åºã¥ãããŒã¿ã
仿ãZBIOã¯2ä»¶ã®ãè²·ããã1ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããZBIOã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯48.429ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q3ã«çºè¡šãããEPS -1.647ã«ç¶ããZBIOã®FY2026Q4ã®EPSã¯-1.309ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -1.65 ã§ããããZenas Biopharma IncZBIO ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -1.77 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -1.31 ãšäºæ³ãããŸãã